![Jim Connolly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Connolly
Directeur/Membre du Conseil chez
VALNEVA SE
Fortune : 51 563 $ au 30/06/2026
Profil
James Edward Connolly currently works at Covenant House, Inc., as Director, Valneva SE, as Independent Director from 2023, and International AIDS Vaccine Initiative, Inc., as Director from 2011.
Mr. Connolly also formerly worked at Tivorsan Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2015 to 2020, Emergent Travel Health, Inc., as Director from 2014 to 2018, Pivotal Therapeutics, Inc., as Director in 2014, Ambulatus Robotics, Inc., as Director from 2020 to 2021, Aeras Global TB Vaccine Foundation, as Director in 2013, Vaxess Technologies, Inc., as Director from 2013 to 2019, Wyeth Pharmaceuticals LLC, as Executive Vice President & General Manager, and Wyeth Canada ULC, as President.
Mr. Connolly received his undergraduate degree from Washington University in St. Louis.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VALNEVA SE 0,01 % | 31/12/2025 | 20 000 ( 0,01 % ) | 51 563 $ | 30/06/2026 |
Postes actifs de Jim Connolly
| Sociétés | Poste | Début |
|---|---|---|
| VALNEVA SE | Directeur/Membre du Conseil | 24/06/2022 |
Covenant House, Inc. | Directeur/Membre du Conseil | - |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Directeur/Membre du Conseil | 01/01/2011 |
Anciens postes connus de Jim Connolly
| Sociétés | Poste | Fin |
|---|---|---|
Ambulatus Robotics, Inc. | Directeur/Membre du Conseil | 02/01/2021 |
Tivorsan Pharmaceuticals, Inc.
 Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of neuromuscular disorders | Directeur Général | 01/01/2020 |
Vaxess Technologies, Inc.
 Vaxess Technologies, Inc. BiotechnologyHealth Technology Develops therapies for oncology care and infectious diseases | Directeur/Membre du Conseil | 01/01/2019 |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Directeur/Membre du Conseil | 01/10/2018 |
| PIVOTAL THERAPEUTICS INC. | Directeur/Membre du Conseil | 23/04/2014 |
Formation de Jim Connolly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
Emergent Travel Health, Inc.
Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Pivotal Therapeutics, Inc.
 Pivotal Therapeutics, Inc. Financial ConglomeratesFinance Operates as a specialty pharmaceutical company | Finance |
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. BiotechnologyHealth Technology Develops therapies for oncology care and infectious diseases | Health Technology |
Wyeth Canada ULC
 Wyeth Canada ULC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Covenant House, Inc. | |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Tivorsan Pharmaceuticals, Inc.
Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of neuromuscular disorders | Health Technology |
Ambulatus Robotics, Inc. |
